Department of Gastroenterology and Hepatology, Imam Reza Hospital, Kermanshah University of Medical Sciences (KUMS), Kermanshah, Iran.
Gastroenterol Res Pract. 2010;2010:170702. doi: 10.1155/2010/170702. Epub 2010 Dec 1.
Objective. The prevalence of Celiac Disease (CD) is high in Iran, and evaluation of CD is not part of the routine screening procedure for dyspeptic patients; therefore, cases of occult CD may be missed. This study aimed to investigate the prevalence of occult CD among dyspeptic patients who presented at a gastroenterology clinic in the Western region of Iran. Methods. In this descriptive, cross-sectional prospective study, patients who had a history of at least 12 weeks of upper abdominal discomfort were eligible to participate in the study during a 14-month recruitment period. Patients with a clinical or paraclinical data in favor of organic causes were excluded from the study. Enrolled patients were screened for IgA antiendomysium antibody (EMA) and IgA antitissue transglutaminase antibody (tTG). Those who screened positive for EMA/tTG received a confirmatory diagnostic biopsy for Marsh classification of CD. Results. From 225 potential participants with dyspepsia, 55 patients were excluded due to having explainable organic causes. The study sample included 170 patients with "functional dyspepsia." Mean age of participants was 31 years and 55.8% were female. Twelve patients (7%) had positive tests (EMA/tTG), of which 10 were female (83.4%). According to Rome II criteria, all twelve patients with positive tests had "dysmotility type dyspepsia." Based on Marsh classification, six patients were consistent with "Marsh I," four with "Marsh II," and two with the "Marsh III" classification. Conclusions. In this study, the prevalence of CD in dyspeptic patients was high. As a result, this study suggests that screening by serology tests (EMA/tTG) is justifiable for the detection of CD among functional dyspeptic patients in the tertiary centers in our country.
目的。 乳糜泻(CD)在伊朗的患病率很高,而且评估 CD 并非消化不良患者常规筛查程序的一部分;因此,可能会错过隐匿性 CD 病例。本研究旨在调查伊朗西部地区一家胃肠病诊所就诊的消化不良患者中隐匿性 CD 的患病率。方法。 在这项描述性、横断面前瞻性研究中,有至少 12 周上腹部不适病史的患者有资格在 14 个月的招募期内参加研究。有临床或辅助检查数据支持器质性原因的患者被排除在研究之外。入组患者接受 IgA 抗内膜抗体(EMA)和 IgA 抗组织转谷氨酰胺酶抗体(tTG)筛查。对 EMA/tTG 筛查阳性的患者进行 CD 的 Marsh 分类诊断性活检。结果。 从 225 名有消化不良症状的潜在参与者中,有 55 名因有可解释的器质性原因而被排除。研究样本包括 170 名“功能性消化不良”患者。参与者的平均年龄为 31 岁,55.8%为女性。12 名患者(7%)的检测结果呈阳性(EMA/tTG),其中 10 名为女性(83.4%)。根据罗马 II 标准,所有 12 名检测结果阳性的患者均有“动力障碍型消化不良”。根据 Marsh 分类,6 名患者符合“Marsh I”,4 名符合“Marsh II”,2 名符合“Marsh III”分类。结论。 在这项研究中,消化不良患者中 CD 的患病率很高。因此,本研究表明,在我国的三级中心,对功能性消化不良患者进行血清学检测(EMA/tTG)筛查可检测 CD。